ZYME
Zymeworks Inc

2,597
Mkt Cap
$1.76B
Volume
69,916.00
52W High
$28.49
52W Low
$9.03
PE Ratio
-27.50
ZYME Fundamentals
Price
$23.29
Prev Close
$23.81
Open
$23.30
50D MA
$24.10
Beta
0.91
Avg. Volume
970,910.05
EPS (Annual)
-$1.62
P/B
5.51
Rev/Employee
$266,797.20
$903.13
Loading...
Loading...

About

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
286

Frequently Asked Questions

What is Market Cap of Zymeworks BC Inc?
What is the 52-week high for Zymeworks BC Inc?
What is the 52-week low for Zymeworks BC Inc?
What is Zymeworks BC Inc stock price today?
What was Zymeworks BC Inc stock price yesterday?
What is the PE ratio of Zymeworks BC Inc?
What is the Price-to-Book ratio of Zymeworks BC Inc?
What is the 50-day moving average of Zymeworks BC Inc?
How many employees does Zymeworks BC Inc have?

Latest ZYME News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.